Microbicide gel dosage prompts call for rethink.
Controversy over a ground-breaking study of an experimental HIV prevention tool has underscored the field’s need to revamp its approach to clinical trials.
Read the story here.
HIV trial doomed by design, say critics
Microbicide gel dosage prompts call for rethink.
Controversy over a ground-breaking study of an experimental HIV prevention tool has underscored the field’s need to revamp its approach to clinical trials.
Read the story here.
Leave a Reply